IL157101A0 - Method for preparing compounds derived from thiazolidinedione, oxazolidinedione or hydantoin - Google Patents

Method for preparing compounds derived from thiazolidinedione, oxazolidinedione or hydantoin

Info

Publication number
IL157101A0
IL157101A0 IL15710102A IL15710102A IL157101A0 IL 157101 A0 IL157101 A0 IL 157101A0 IL 15710102 A IL15710102 A IL 15710102A IL 15710102 A IL15710102 A IL 15710102A IL 157101 A0 IL157101 A0 IL 157101A0
Authority
IL
Israel
Prior art keywords
oxazolidinedione
thiazolidinedione
hydantoin
preparing compounds
compounds derived
Prior art date
Application number
IL15710102A
Other languages
English (en)
Original Assignee
Ppg Sipsy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0102010A external-priority patent/FR2820741A1/fr
Application filed by Ppg Sipsy filed Critical Ppg Sipsy
Publication of IL157101A0 publication Critical patent/IL157101A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/44Two oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72Two oxygen atoms, e.g. hydantoin
    • C07D233/76Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • C07D233/78Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/96Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Catalysts (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL15710102A 2001-02-14 2002-02-14 Method for preparing compounds derived from thiazolidinedione, oxazolidinedione or hydantoin IL157101A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0102010A FR2820741A1 (fr) 2001-02-14 2001-02-14 Procede de preparation de composes derives de thiazolidinedione, d'oxazolidinedione ou d'hydantoine
FR0105206A FR2820742B1 (fr) 2001-02-14 2001-04-17 Procede de preparation de composes derives de thiazolidinedione, d'oxazolidinedione ou d'hydantoine
PCT/FR2002/000571 WO2002064577A2 (fr) 2001-02-14 2002-02-14 Procede de preparation de composes derives de thiazolidinedione, d'oxazolidinedione

Publications (1)

Publication Number Publication Date
IL157101A0 true IL157101A0 (en) 2004-02-08

Family

ID=26212876

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15710102A IL157101A0 (en) 2001-02-14 2002-02-14 Method for preparing compounds derived from thiazolidinedione, oxazolidinedione or hydantoin

Country Status (13)

Country Link
US (1) US6849741B2 (de)
EP (1) EP1360179A2 (de)
JP (1) JP2004520401A (de)
KR (1) KR100856140B1 (de)
CN (1) CN1491218A (de)
AU (1) AU2002238645A1 (de)
BR (1) BR0206967A (de)
CA (1) CA2438105A1 (de)
FR (1) FR2820742B1 (de)
IL (1) IL157101A0 (de)
MX (1) MXPA03007263A (de)
RU (1) RU2003127720A (de)
WO (1) WO2002064577A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2470075A1 (en) * 2001-12-20 2003-07-03 Teva Pharmaceutical Industries Ltd. Hydrogenation of precursors to thiazolidinedione antihyperglycemics
CZ297347B6 (cs) * 2004-09-21 2006-11-15 Zentiva, A. S. Zpusob prípravy rosiglitazonu
EP1903042A3 (de) * 2006-09-22 2008-05-28 Cadila Pharmaceuticals Limited Ein verbessertes Verfahren zur Hydrierung von Zusammensetzungen aus 5-(substitutiertem Benzyliden) 2,4- Thiazolidin-Dion, um das entsprechende ( +/- ) 5- (substituierte Benzyl) 2,4-Thiazolidin-Dion zu erzeugen

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4812570A (en) * 1986-07-24 1989-03-14 Takeda Chemical Industries, Ltd. Method for producing thiazolidinedione derivatives
ATE205206T1 (de) * 1990-04-27 2001-09-15 Sankyo Co Benzylidenthiazolidinderivate, ihre herstellung und ihre anwendung als lipidperoxid-inhibitoren
US5585495A (en) * 1991-12-20 1996-12-17 The Upjohn Company Reduction method for substituted 5-methylene-thiazolidinediones
JP3163361B2 (ja) * 1992-03-12 2001-05-08 味の素株式会社 5−アルキルヒダントイン誘導体の製造法
US5399632A (en) * 1992-09-30 1995-03-21 Exxon Research & Engineering Co. Hydrogenation process for unsaturated homo and copolymers
JPH06199808A (ja) * 1993-01-04 1994-07-19 Ajinomoto Co Inc 5−シクロヘキシルメチルヒダントイン誘導体の製造方法およびその製造中間体
JPH08277279A (ja) * 1995-04-05 1996-10-22 Nitto Chem Ind Co Ltd ベンジルチアゾリジンジオン誘導体の製造方法
US5952509A (en) * 1996-06-27 1999-09-14 Takeda Chemical Industries, Ltd. Production of benzaldehyde compounds
UY24886A1 (es) * 1997-02-18 2001-08-27 Smithkline Beecham Plc Tiazolidindiona
DE19711616A1 (de) * 1997-03-20 1998-09-24 Boehringer Mannheim Gmbh Verbessertes Verfahren zur Herstellung von Thiazolidindionen
JP4084501B2 (ja) * 1999-07-01 2008-04-30 三井化学株式会社 α−メルカプトカルボン酸およびその製造方法

Also Published As

Publication number Publication date
EP1360179A2 (de) 2003-11-12
MXPA03007263A (es) 2005-02-14
KR20030082594A (ko) 2003-10-22
CA2438105A1 (fr) 2002-08-22
FR2820742B1 (fr) 2005-03-11
KR100856140B1 (ko) 2008-09-03
US20040059121A1 (en) 2004-03-25
BR0206967A (pt) 2004-03-09
JP2004520401A (ja) 2004-07-08
RU2003127720A (ru) 2005-03-20
FR2820742A1 (fr) 2002-08-16
CN1491218A (zh) 2004-04-21
WO2002064577A2 (fr) 2002-08-22
AU2002238645A1 (en) 2002-08-28
US6849741B2 (en) 2005-02-01
WO2002064577A3 (fr) 2003-01-03

Similar Documents

Publication Publication Date Title
AP2005003264A0 (en) Novel imidazole compounds as transforming growth factor (TGD) inhibitors.
MXPA03005284A (es) Nuevo procedimiento para la sintesis de fenilamida del acido 5-(4-flourofenil) -1-[2-((2r, 4r)-4-hidroxi -6-oxotetrahidro -piran-2-il) -etil]-2-isopropil -4-fenil-1h -pirrol-3-carboxilico.
ZA200203252B (en) Process for preparing 4"-substituted-9-deoxo-9A-AZA-9A-homoerythromycina derivatives.
EG23299A (en) Process for preparing 1-octene.
ZA200402472B (en) Method for preparing benzenesulfonyl compounds.
HUP0203333A3 (en) Method for stabilizing benzimidazole compounds
ZA200309471B (en) Method for the preparation of escitalopram.
HUP0500037A3 (en) Process for preparing insulin compounds
ZA200403432B (en) Method for the preparation of escitalopram.
MXPA03008205A (es) Procedimiento para la preparacion de compuestos de imidazol.
IL150043A0 (en) Method for preparing bromodifluoroacetic compounds
WO2001007408A3 (fr) Nouveau procede de preparation de composes benzoperhydroisoindole
IL157101A0 (en) Method for preparing compounds derived from thiazolidinedione, oxazolidinedione or hydantoin
ZA200305338B (en) An improved process for preparing pure ondansetron hydrochloride dihydrate.
PL371913A1 (en) Method for synthesizing beta-l-fluoro-2',3'-dideoxy-didehydcytidine (beta-l-fd4c)
AU2003222342A1 (en) Method for preparing $g(v)-bromoalkylcarboxylic compounds
GB2380320B (en) Method for the sulphidation treatment of 111-V compound semiconductor surfaces
AU5031200A (en) Method for preparing 5-substituted oxazoles
HUP0401439A3 (en) Method for synthesis of 5-(3-pyridylmethylene)-imidazolidine-2,4-dione
HUP0401401A3 (en) Method for preparing 7-quinolinyl-3,5-dihydroxyhept-6-enoate
AU2003259866A8 (en) Process for preparing 3-chloromethyl-1,2,4-triazolin-5-one
AU2002364618A1 (en) Method for preparing an aminobenzofuran compound
AU2002300794A1 (en) Process for preparing 4,5-dihydro-1,3-thiazoles
AU2003253256A1 (en) Improved process for the preparation of 5-substituted-1-(4--fluorophenyl)-1,3-dihydroisobenzofurans
HUP0300723A3 (en) Process for the preparation of 5-[(4-chlorophenyl)-methyl]-2,2-dimethylcylopentanone